Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

24 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
MRI enhancing lesion frequency from patients with MS enrolled in the placebo arms of clinical trials or in natural history studies.
Sormani MP, Molyneux PD, Barkhof F, Miller DH, Filippi M. Sormani MP, et al. Magn Reson Imaging. 1999 Oct;17(8):1236-7. doi: 10.1016/s0730-725x(99)00070-3. Magn Reson Imaging. 1999. PMID: 10499687 Clinical Trial. No abstract available.
The use of magnetic resonance imaging in multiple sclerosis treatment trials: power calculations for annual lesion load measurement.
Molyneux PD, Miller DH, Filippi M, Yousry T, Kappos L, Gasperini C, Adèr HJ, Barkhof F. Molyneux PD, et al. J Neurol. 2000 Jan;247(1):34-40. doi: 10.1007/s004150050007. J Neurol. 2000. PMID: 10701895
Clinical-MRI correlations in a European trial of interferon beta-1b in secondary progressive MS.
Molyneux PD, Barker GJ, Barkhof F, Beckmann K, Dahlke F, Filippi M, Ghazi M, Hahn D, MacManus D, Polman C, Pozzilli C, Kappos L, Thompson AJ, Wagner K, Yousry T, Miller DH; European Study Group on Interferon Beta-1b in Secondary Progressive MS. Molyneux PD, et al. Neurology. 2001 Dec 26;57(12):2191-7. doi: 10.1212/wnl.57.12.2191. Neurology. 2001. PMID: 11756596 Clinical Trial.
The effect of IFNbeta-1b on the evolution of enhancing lesions in secondary progressive MS.
Brex PA, Molyneux PD, Smiddy P, Barkhof F, Filippi M, Yousry TA, Hahn D, Rolland Y, Salonen O, Pozzilli C, Polman CH, Thompson AJ, Kappos L, Miller DH; European Study Group on Interferon beta-1b in Secondary Progressive MS. Brex PA, et al. Among authors: molyneux pd. Neurology. 2001 Dec 26;57(12):2185-90. doi: 10.1212/wnl.57.12.2185. Neurology. 2001. PMID: 11756595 Clinical Trial.
Statistical power of MRI monitored trials in multiple sclerosis: new data and comparison with previous results.
Sormani MP, Molyneux PD, Gasperini C, Barkhof F, Yousry TA, Miller DH, Filippi M. Sormani MP, et al. J Neurol Neurosurg Psychiatry. 1999 Apr;66(4):465-9. doi: 10.1136/jnnp.66.4.465. J Neurol Neurosurg Psychiatry. 1999. PMID: 10201417 Free PMC article.
Precision and reliability for measurement of change in MRI lesion volume in multiple sclerosis: a comparison of two computer assisted techniques.
Molyneux PD, Tofts PS, Fletcher A, Gunn B, Robinson P, Gallagher H, Moseley IF, Barker GJ, Miller DH. Molyneux PD, et al. J Neurol Neurosurg Psychiatry. 1998 Jul;65(1):42-7. doi: 10.1136/jnnp.65.1.42. J Neurol Neurosurg Psychiatry. 1998. PMID: 9667559 Free PMC article. Clinical Trial.
Sample size estimations for MRI-monitored trials of MS comparing new vs standard treatments.
Sormani MP, Rovaris M, Bagnato F, Molyneux P, Bruzzi P, Pozzilli C, Miller DH, Comi G, Filippi M. Sormani MP, et al. Neurology. 2001 Nov 27;57(10):1883-5. doi: 10.1212/wnl.57.10.1883. Neurology. 2001. PMID: 11723280
The precision of T1 hypointense lesion volume quantification in multiple sclerosis treatment trials: a multicenter study.
Molyneux PD, Brex PA, Fogg C, Lewis S, Middleditch C, Barkhof F, Sormani MP, Filippi M, Miller DH. Molyneux PD, et al. Mult Scler. 2000 Aug;6(4):237-40. doi: 10.1177/135245850000600405. Mult Scler. 2000. PMID: 10962544
24 results
Jump to page